Contributing to tomorrow's health through peptide research! The best partner for the commercialization of research results.
ProtoCell Inc. continues to provide tests and proprietary technologies utilizing the results of peptide dome analysis research as services for preventive medicine. Our ProtoKey cancer risk test starts with biomarker discovery through joint research with universities and realizes delivery to the market. Our in-house laboratory and hygiene testing facility are equipped with advanced experimental equipment, and we have research and development, testing, sales, and business development departments, allowing us to consistently carry out everything from research and development to service provision. 【Business Activities】 ■ Clinical testing contract business (testing contract services at our registered hygiene testing facility, proprietary cancer risk tests, etc.) ■ Research and development support business (contract services such as peptide marker discovery) *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company provides services for disease prevention (Protokey testing) and treatment (receptor-targeted drugs) based on human peptide research. "Protokey testing" is an examination that uses blood bio-marker peptides discovered through our proprietary BLOTCHIP-MS method to assess the risk of various diseases. We conduct biomarker exploration research in collaboration with many universities in Japan and analyze a variety of diseases. Additionally, we offer contract services such as "peptide marker exploration," which involves searching for peptides that could serve as new biomarkers.